Article
Synergy Between Two Chimeric Lysins to Kill Streptococcus pneumoniae
5 Jun 2019
Abstract excerpt
Phage lysins constitute a new generation of antimicrobials that are becoming a promising alternative and complementation to current antibiotic therapies, which are nowadays called into question by the increasing numbers of multiresistant bacteria. Streptococcus pneumoniae is a leading human pathogen causing serious infectious diseases in children and adults. Within the host-parasite interplay system of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
